SD01 Master Study (Safety and Efficacy Study)
Last updated on April 2022Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 160
Inclusion Criteria
- Legal capacity and ability to consent.
- Patient is willing and able to activate and use the CardioMessenger
- Standard indication for an ICD/CRT-D therapy
- ...
- Legal capacity and ability to consent.
- Patient is willing and able to activate and use the CardioMessenger
- Standard indication for an ICD/CRT-D therapy
- Patient is willing and able to participate for the whole study duration
- Signed informed consent form
Exclusion Criteria
- Pregnant or breastfeeding
- Mechanical tricuspid valve prosthesis or severe tricuspid valve disease
- Cardiac surgery is planned within the next six months
- ...
- Pregnant or breastfeeding
- Mechanical tricuspid valve prosthesis or severe tricuspid valve disease
- Cardiac surgery is planned within the next six months
- Dexamethasone acetate intolerance
- Age <18 years.
- Any condition that in the opinion of the investigator would preclude compliance with the study protocol during the whole follow-up period
- Enrollment in another cardiac clinical investigation with active treatment arm
- Standard contraindication for an ICD/CRT-D therapy
Summary
- Conditions
- Heart Failure
- Ventricular Fibrillation
- Ventricular Tachycardia
- Type
- Observational
- Design
- Observational Model: Case-Only
- Time Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Inclusion Criteria
- Legal capacity and ability to consent.
- Patient is willing and able to activate and use the CardioMessenger
- Standard indication for an ICD/CRT-D therapy
- ...
- Legal capacity and ability to consent.
- Patient is willing and able to activate and use the CardioMessenger
- Standard indication for an ICD/CRT-D therapy
- Patient is willing and able to participate for the whole study duration
- Signed informed consent form
Exclusion Criteria
- Pregnant or breastfeeding
- Mechanical tricuspid valve prosthesis or severe tricuspid valve disease
- Cardiac surgery is planned within the next six months
- ...
- Pregnant or breastfeeding
- Mechanical tricuspid valve prosthesis or severe tricuspid valve disease
- Cardiac surgery is planned within the next six months
- Dexamethasone acetate intolerance
- Age <18 years.
- Any condition that in the opinion of the investigator would preclude compliance with the study protocol during the whole follow-up period
- Enrollment in another cardiac clinical investigation with active treatment arm
- Standard contraindication for an ICD/CRT-D therapy
Tracking Information
- NCT #
- NCT01836497
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Roland Richard Tilz, Prof. Dr. med. University Clinic of Schleswig-Holstein, Lübeck, Germany
- Roland Richard Tilz, Prof. Dr. med. University Clinic of Schleswig-Holstein, Lübeck, Germany